Kirby McInerney LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Class Action Filing and Encourages Investors to Contact the Firm
16 janv. 2025 17h28 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors who purchased BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ:BIOA) securities to contact...
Kirby McInerney LLP Announces Investigation Against TELUS International (Cda) Inc. (TIXT) on Behalf of Investors
16 janv. 2025 16h58 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against TELUS International (Cda) Inc. (“TELUS” or the “Company”) (NYSE:TIXT). The...
Kirby McInerney LLP Announces Investigation Against TransMedics Group, Inc. (TMDX) on Behalf of Investors
16 janv. 2025 16h56 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ:TMDX). The...
XRX INVESTOR ALERT: Kirby McInerney LLP Reminds Xerox Holdings Corporation Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
10 janv. 2025 11h00 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP notifies investors of the approaching January 21, 2025, deadline to seek the role of lead plaintiff in a federal...
HUMA INVESTOR ALERT: Kirby McInerney LLP Reminds Humacyte, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit
10 janv. 2025 11h00 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP notifies investors of the approaching January 17, 2025, deadline to seek the role of lead plaintiff in a federal...
Kirby McInerney LLP Reminds Revance Therapeutics, Inc. (RVNC) Investors of Class Action Filing and Encourages Investors to Contact the Firm
10 janv. 2025 08h00 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors who purchased Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ:RVNC) securities to...
RTO INVESTOR ALERT: Kirby McInerney LLP Notifies Rentokil Initial plc Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
08 janv. 2025 20h00 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the January 27, 2025, deadline to seek the role of lead plaintiff in a federal securities class...
SYM INVESTOR ALERT: Kirby McInerney LLP Notifies Symbotic Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
08 janv. 2025 20h00 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the February 3, 2025, deadline to seek the role of lead plaintiff in a federal securities class...
FIVN INVESTOR ALERT: Kirby McInerney LLP Notifies Five9, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
07 janv. 2025 20h00 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the February 3, 2025, deadline to seek the role of lead plaintiff in a federal securities class...
MGPI INVESTOR ALERT: Kirby McInerney LLP Notifies MGP Ingredients, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
07 janv. 2025 20h00 HE
|
Kirby McInerney LLP
NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the February 14, 2025, deadline to seek the role of lead plaintiff in a federal securities class...